Exela Technologies Confirms Receipt Of Acquisition Proposal

Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ:XELA, XELAP)))) today confirmed that it has received a preliminary, non-binding proposal (the "Proposal") to acquire an

Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA, XELAP))))) today confirmed that it has received a preliminary, non-binding proposal (the “Proposal”) to acquire an approximately $200 million revenue business unit of Exela, subject to certain conditions, including due diligence. The Company is in active discussions with several counter-parties about additional acquisition proposals.

On June 6, 2022 the Company announced its strategic plans initiating the sale process for several standalone assets, as part of a broader mandate to maximize shareholder value, including further reduction, exchange of debt, lowering its overall annual interest expense and/or repurchasing common stock. The Company is evaluating the Proposal as well as other strategic alternatives which may enhance shareholder value.
 

Consistent with its fiduciary duties and in consultation with its financial and legal advisors, Exela’s Board of Directors will carefully review the Proposal. There can be no assurances that any definitive agreement will be executed or that a transaction will be approved or consummated. The Company does not undertake any obligation to provide updates with respect to this or any other transaction, except as required under applicable law.

Total
0
Shares
Related Posts
Read More

Reneo Pharmaceuticals Inc Says On Dec 26, Concentra, An Affiliate Of Tang Capital Partners, Sent Acquisition Proposal To The Co; On Behalf Of Concentra Biosciences, Submit Non-Binding Proposal To Acquire 100% Of Equity Of Reneo For $1.80 Per Share

Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmaceuticals, Inc.c/o Gregory J. Flesher, President and Chief Executive Officer18575

RPHM

Read More

Why Is Cultivation Solutions Provider Agrify Stock Soaring Today?

Shares of Agrify Corporation surge following the announcement of its acquisition by Nature's Miracle Holding Inc. The proposed deal, set to exchange 0.45 shares of Nature's Miracle for each Agrify share, positions Agrify's SaaS and AI technology as a lucrative revenue stream for Nature's Miracle, while Agrify gains access to cutting-edge horticultural lighting technologies.

AGFY